Experiment 644617
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | CASTANO,G: MAS,R: FERNANDEZ,JC: PONTIGAS,V: SUAZO,M: FERNANDEZ,L:. (1998). OPEN-LABEL STUDY OF THE EFFICACY, SAFETY, AND TOLERABILITY OF POLICOSANOL IN PATIENTS WITH HIGH GLOBAL CORONARY RISK.. 59(10) |
| Amount utilized | |
| Compound isolated | |
| Disease | AN OPERN-LABEL SHORT-TERM STUDY WAS USED TO STUDY THE EFRFECTS OF POLICOSANOL IN THE TREATMENT OF PATIENTS WITH TYPE IT HYPERCHOLESTEROLEMIA AND HIGHT GLOBAL CORONARY RISK. AFTER 8 WEEKS POLICOSANOL SIGNIFICANTLY REDUCED LOW-DINSITY LIPOPROTEIN CHOLESTEROL (LDL-C) (22.6%) AND TOTAL CHOLESTEROL (16.9%) AND INCREASED HIGH DENSITY LIPOPROTEIN CHOLESTEROL (20.0%). TRIGLYCERIDES DID NOT CHANGE. |
| Dose amount | 20.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |